Regeneron Pharmaceuticals Inc (REGN)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$704.00

Buy

$743.50

arrow-down$-5.51 (-0.74%)

Prices updated at 13 Dec 2025, 00:51 EST

Prices minimum 15 mins delay

Prices in USD

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	13,117m	14,202m
	11,301m	12,232m
	4,233m	4,092m
	32.27	28.81
	3,954m	4,413m
	4,693m	5,318m
Sales, General and administrative	2,631m	2,954m
Interest expenses	73m	55m
Provision for income taxes	246m	367m
Operating expenses	7,068m	8,140m
Income before taxes	4,199m	4,780m
Net income available to common shareholders	3,954m	4,413m
	37.05	40.9
Net interest income	423m	656m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	34.77	38.34
Free cash flow per share	38.3049	28.8321
Book value/share	227.6076	267.5302
Debt equity ratio	0.104065	0.092132

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	19,479m	18,661m
Current liabilities	3,423m	3,944m
Total capital	27,956m	31,338m
Total debt	2,703m	2,704m
Total equity	25,973m	29,354m
Total non current liabilities	-	-
Loans	1,983m	1,984m
Total assets	33,080m	37,759m
Total liabilities	-	-
Cash and cash equivalents	2,730m	2,488m
Common stock	109m	110m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	3,119m	2,738m
Cash dividends paid	-	-
	3,668m	3,539m
Investments (gains) losses	-3,185m	-2,468m
	2,738m	2,489m
Net income	-	-
	4,594m	4,421m
	-926m	-882m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.